African Health Markets for Equity (AHME) IMPACT EVALUATION
How to cite
GERTLER, PAUL. 2014. "African Health Markets for Equity (AHME) IMPACT EVALUATION." AEA RCT Registry. AEARCTR-0000217. https://doi.org/10.1257/rct.217-2.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
The African Health Markets for Equity (AHME) Impact Evaluation aims to rigorously evaluate the extent to which transforming the business model of franchised healthcare providers and expanding access to demand-side financing generates effective and cost-effective coverage of priority technologies and interventions amongst the poor. The evaluation is a collaborative effort between Innovations for Poverty Action and researchers from multiple institutions, and is funded by the Bill and Melinda Gates Foundation and the Department for International Development of the United Kingdom of Great Britain and Northern Ireland (DFID). The AHME intervention package will seek to improve efficiencies in private health care delivery by reducing both supply-side and demand-side constraints. Specifically, supply-side intervention will include (1) the social franchising of private clinics in order to improve consistency and quality of care and to reduce costs and (2) quality monitoring linked to capital financing in order to help clinics expand and improve clinical services. On the demand side, AHME interventions, such as vouchers, health insurance schemes and medical savings accounts will be integrated into the AHME package in later years to reduce financial barriers to accessing provider services. In addition opportunities to improve the operational efficiency of supply and/or demand-side financing interventions using information and communication technology (ICT) interventions will be explored.
The AHME intervention package will be evaluated using a randomized control trial (RCT) design. The RCT will be designed to measure the effectiveness and cost-effectiveness of the AHME model (franchising, supply-side financing and demand-side financing) at improving quality of care, service utilization, access to high-quality care, and health outcomes. Clinics will be screened for eligibility during baseline data collection. Using criteria established by the AHME implementing partners, clinics will be grouped by how likely they are to be eligible for the AHME package of interventions. Clinics in top eligibility tiers (those most likely to be eligible for the package of AHME interventions) will be randomly assigned a number to determine the order in which they will be approached for recruitment into AHME. Random assignment will be stratified by county and eligibility tier. The top half of the list will be assigned to the treatment group (clinics that should be approached for recruitment to the AHME package immediately) and the control group (clinics that will be recruited after the completion of the AHME evaluation). The random number assigned to each clinic will also determine the order in which clinics will be approached within both treatment and controls arms. Subsequent interventions (i.e., demand-side financing and information and communication technology interventions) will be randomly allocated in a similar fashion. Data will be collected over a 4 year period at both the clinic and household level to measure healthcare utilization and quality of care, clinic financial outcomes, and child health outcomes. Outcomes will be compared between treatment and control clinics to estimate impacts of the overall AHME package. Cost-effectiveness analyses will also conducted
Intervention
The AHME package is a set of interventions that seek to improve private health care delivery inefficiencies by integrating supply- and demand-side interventions. The primary focus of the supply-side interventions will be to improve and expand the delivery of high quality health care services through a private network of providers. In the first stage of the supply-side intervention, AHME implementation partners Marie Stopes International (MSI) and Population Services International (PSI) will expand the scope and scale of their existing franchise model. MSI and PSI will expand the scope of existing family planning services to include: maternal and perinatal care, and malaria, diarrhea, and pneumonia treatment services for children less than 5 years old (with plans to add child nutrition and TB services in later years). In addition, MSI and PSI will expand the scale of their services to include new private clinics in both Eastern and Western Kenya. MSI and PSI will recruit new providers (private clinics) to their respective franchise models and provide training and support in franchised services (e.g., clinical protocols and clinical best practices), subsidize select clinical materials, and provide marketing (branding and community demand generation messaging). As part of their recruitment into the MSI and PSI franchises, private clinics agree to maintain records that MSI/PSI can monitor for quality assurance (annual visits), abide by price limits for services and materials, and pay membership fees. The franchise intervention will be rolled out in the first year of the intervention among randomly selected clinics; the order in which treatment clinics are recruited by MSI and PSI will also be randomized.
In conjunction with franchising efforts, PharmAccess will roll out its "SafeCare"/Medical Credit Fund (MCF) intervention to MSI/PSI franchisees. The goal of the SafeCare/MCF intervention is to first improve quality assurance systems within clinics by providing clinics with a quality improvement plan based on observed operations. The SafeCare process includes a monitoring system with step-based certificates to reward clinic quality improvements. As clinics achieve "higher" steps (improve quality) they will become eligible for MCF loans. It is expected that increased access to capital will allow providers (private clinics) to make the necessary investment to further improve the quality and range of services they offer.
Demand-side financing (DSF) and information and communication technology (ICT) components of the AHME package will be randomly overlayed franchising and supply-side financing interventions in later years of the evaluation. DSF interventions could include vouchers, health insurance schemes, and medical savings accounts.
Experimental design
The overall impact of the AHME package of interventions will be estimated using a randomized control trial design (RCT). During baseline data collection, clinics in counties throughout Eastern and Western Kenya will be mapped and screened by Innovations for Poverty Action (IPA), using established MSI and PSI criteria and protocols. Clinics that are considered "likely" to be eligible are assigned a randomly generated number by the investigators in order to 1) assign clinics to intervention (early recruitment), or control (recruitment at the end of the study) and 2) determine the sequence in which clinics are approached to be recruited for franchising and SafeCare/Medical Credit Fund by the implementation partners. In Year 1, after baseline clinic data collection, and randomization are complete, MSI and PSI will approach clinics for final determination of franchise eligibility and for recruitment. SafeCare/MCF interventions will also be rolled out in Year 1 as part of the AHME package and will follow the same recruitment order as that used for franchising recruitment. In Year 2, treated clinics will receive demand-side financing interventions when PSI and MSI provide training and support to their franchised clinics to register with NHIF and to improve clients’ experience in using NHIF at their clinics.
Four rounds of data collection will be used to measure baseline characteristics, and evaluation outcomes. In Year 1 (Q4: 2013) baseline surveys will be conducted in all clinics. In addition, clinic exit surveys will be used to identify and collect contact information from a sample of clinic clientele, and ask permission to visit their homes to conduct a baseline household interview. In Year 2 (Q1: 2015), follow up surveys will be conducted in all clinics to measure intermediate clinic outcomes, and to monitor intervention implementation. In Years 3 and 4 (Q1: 2016; Q1: 2017) full follow ups surveys will be conducted in all clinics and all households to measure longer-term impacts of the AHME package and to measure incremental impacts of DSF and ICT interventions.
This randomized design will allow us to directly compare outcomes in the intervention and control arms, and identify the effect of the intervention. Since not all clinics will agree to be franchised, or participate in SafeCare/MCF, intention-to-treat (ITT) principles will used to identify an unbiased effect of offering the package to the clinic. The effect of the treatment on the treated will be estimated by using an instrumental variables approach. In addition, randomizing the order in which clinics are approached for the intervention packages will allow us to estimate "dose responses", as different clinics will be on treatment for different amounts of time at each follow up round.
Design details
Cited by
No citation data available for this registration yet.